Evidence map›Paper›PMID 41683493›Full record

ArticleMolecules (Basel, Switzerland)2026

Tina Novaković, Emina Mehmedović, Maja Krstić Ristivojević, Ivana Prodić, Vesna Jovanović, Milica Aćimović, Katarina Smiljanić

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tina NovakovićUniversity Clinical Centre of Serbia, University of Belgrade-Faculty of Medicine, 11000 Belgrade, Serbia.ORCID 0009-0002-4658-6425
Emina MehmedovićFaculty of Technology and Faculty of Natural Sciences and Mathematics, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina.ORCID 0009-0002-8616-0525
Maja Krstić RistivojevićCoE for Molecular Food Sciences, Department of Biochemistry, University of Belgrade-Faculty of Chemistry, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0002-8794-9408
Ivana ProdićInstitute of Virology, Vaccines and Sera "Torlak"-National Institute of the Republic of Serbia, Vojvode Stepe 458, 11152 Belgrade, Serbia.ORCID 0000-0003-0604-9246
Vesna JovanovićCoE for Molecular Food Sciences, Department of Biochemistry, University of Belgrade-Faculty of Chemistry, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0001-9356-0813
Milica AćimovićInstitute of Field and Vegetable Crops-National Institute of the Republic of Serbia, 21101 Novi Sad, Serbia.ORCID 0000-0002-5346-1412
Katarina SmiljanićCoE for Molecular Food Sciences, Department of Biochemistry, University of Belgrade-Faculty of Chemistry, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0003-4774-8895

Funding

Ministry of Science, Technology and Innovation, Republic of Serbia 451-03-136/2025-03/200168, awarded to UBFC and 451-03-136/2025-03/200177, awarded to the Torlak Institute.
6 · The paper itself

Abstract

backgroundSerum-free culture of red blood cells (RBCs) typically leads to rapid loss of viability, limiting experimental and translational applications. Lipid-rich formulations and essential oils may provide biocompatible support for RBC integrity while limiting microbial overgrowth.

methodsRBCs from nine healthy adult donors were cultured in serum-free RPMI under four conditions: control, vehicle (olive oil, 1:100

resultsGenuine ATP-oil

conclusionsSupplementation with ATP-oil

Indexed as

BacteriaErythrocytesMentha piperitaOils, VolatileOlive OilAdenosine TriphosphateCell SurvivalCulture Media, Serum-FreeHumansAdenosine TriphosphateCulture Media, Serum-FreeOils, VolatileOlive OilATP-oil®bacterial contaminationerythrocyte survivalpeppermint essential oilred blood cellserum-free culturetransfusion safety

Identifiers

PMID41683493
PMCPMC12899880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.